PMID- 32871960 OWN - NLM STAT- MEDLINE DCOM- 20200914 LR - 20221005 IS - 1536-5964 (Electronic) IS - 0025-7974 (Print) IS - 0025-7974 (Linking) VI - 99 IP - 35 DP - 2020 Aug 28 TI - Fecal microbiota transplantation therapy for Parkinson's disease: A preliminary study. PG - e22035 LID - 10.1097/MD.0000000000022035 [doi] LID - e22035 AB - Imbalances in the gut microbiota mediate the progression of neurodegenerative diseases such as Parkinson's disease (PD). Fecal microbiota transplantation (FMT) is currently being explored as a potential therapy for PD. The objective of this study was to assess the efficacy and safety of FMT on PD. Fifteen PD patients were included, 10 of them received FMT via colonoscopy (colonic FMT group) and 5 received FMT via nasal-jejunal tube (nasointestinal FMT group). The score of PSQI, HAMD, HAMA, PDQ-39, NMSQ and UPDRS-III significantly decreased after FMT treatment (all P < .05). Colonic FMT group showed significant improvement and longer maintenance of efficacy compared with nasointestinal FMT (P = .002). Two patients achieved self-satisfying outcomes that last for more than 24 months. However, nasointestinal FMT group had no significant therapeutic effect, although UPDRS-III score slightly reduced. There were no patients were satisfied with nasointestinal FMT for more than 3 months. Among 15 PD patients, there were 5 cases had adverse events (AEs), including diarrhea (2 cases), abdominal pain (2 cases) and flatulence (1 case). These AEs were mild and self-limiting. We conclude that FMT can relieve the motor and non-motor symptoms with acceptable safety in PD. Compared with nasointestinal FMT, colonic FMT seems better and preferable. FAU - Xue, Liu-Jun AU - Xue LJ AD - Department of Neurology, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University. FAU - Yang, Xiao-Zhong AU - Yang XZ AD - Department of Gastroenterology, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huaian, Jiangsu Province, China. FAU - Tong, Qiang AU - Tong Q AD - Department of Neurology, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University. FAU - Shen, Peng AU - Shen P AD - Department of Gastroenterology, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huaian, Jiangsu Province, China. FAU - Ma, Shi-Jie AU - Ma SJ AD - Department of Gastroenterology, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huaian, Jiangsu Province, China. FAU - Wu, Shang-Nong AU - Wu SN AD - Department of Gastroenterology, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huaian, Jiangsu Province, China. FAU - Zheng, Jin-Long AU - Zheng JL AD - Department of Neurology, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University. FAU - Wang, Hong-Gang AU - Wang HG AUID- ORCID: 0000-0003-4761-0407 AD - Department of Gastroenterology, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huaian, Jiangsu Province, China. LA - eng PT - Journal Article PL - United States TA - Medicine (Baltimore) JT - Medicine JID - 2985248R SB - IM MH - Aged MH - Colonoscopy MH - Fecal Microbiota Transplantation/adverse effects/methods/*statistics & numerical data MH - Female MH - Humans MH - Intubation, Gastrointestinal MH - Male MH - Middle Aged MH - Parkinson Disease/*therapy MH - Patient Satisfaction MH - Pilot Projects MH - Young Adult PMC - PMC7458210 COIS- The authors report no conflicts of interest. EDAT- 2020/09/03 06:00 MHDA- 2020/09/15 06:00 PMCR- 2020/08/28 CRDT- 2020/09/03 06:00 PHST- 2020/09/03 06:00 [entrez] PHST- 2020/09/03 06:00 [pubmed] PHST- 2020/09/15 06:00 [medline] PHST- 2020/08/28 00:00 [pmc-release] AID - 00005792-202008280-00103 [pii] AID - MD-D-20-04459 [pii] AID - 10.1097/MD.0000000000022035 [doi] PST - ppublish SO - Medicine (Baltimore). 2020 Aug 28;99(35):e22035. doi: 10.1097/MD.0000000000022035.